Foresite Capital Opportunity Management V as of June 30, 2022
Portfolio Holdings for Foresite Capital Opportunity Management V
Foresite Capital Opportunity Management V holds 9 positions in its portfolio as reported in the June 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Pardes Biosciences | 40.4 | $16M | 5.2M | 3.07 | |
| Theseus Pharmaceuticals | 13.4 | $5.3M | 959k | 5.53 | |
| Compass Therapeutics (CMPX) | 10.4 | $4.1M | 1.6M | 2.65 | |
| Gemini Therapeutics | 10.4 | $4.1M | 2.4M | 1.69 | |
| Kinnate Biopharma | 9.3 | $3.7M | 292k | 12.61 | |
| Adicet Bio (ACET) | 6.3 | $2.5M | 170k | 14.60 | |
| Quantum-Si Incorporated Com Cl A (QSI) | 3.7 | $1.5M | 634k | 2.32 | |
| Hims & Hers Health Com Cl A (HIMS) | 3.5 | $1.4M | 306k | 4.53 | |
| Enanta Pharmaceuticals (ENTA) | 2.7 | $1.1M | 23k | 47.25 |
